Crossmark

The structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders

Crossref DOI link: https://doi.org/10.1007/s00775-018-1605-1

Published Online: 2018-08-21

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pozzi, Cecilia https://orcid.org/0000-0003-2574-3911
Di Pisa, Flavio https://orcid.org/0000-0003-2302-1464
Benvenuti, Manuela https://orcid.org/0000-0003-0709-2537
Mangani, Stefano https://orcid.org/0000-0003-4824-7478
Funding

Funding for this research was provided by:

BioStruct-X (grant agreement No. 283570)
License Information

Text and Data Mining valid from 2018-08-21
More Information

Article History

Received: 29 June 2018

Accepted: 16 August 2018

First Online: 21 August 2018

Document is current

Any future updates will be listed below